NPS Pharmaceuticals (NPSP) 45.97 $NPSP Shire to buy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
NPS Pharmaceuticals (NPSP) 45.97 $NPSP

Shire to buy Baxalta for around $32 billion
M2 - Tue Jan 12, 6:03AM CST
"The target Baxalta and the orphan disease market are very compelling. The market is very attractive; worth $100+ Billion and has a CAGR of12 percent, almost twice of the general drugs market. Of the top 10 projected best-selling drugs world-wide in 2015, almost seven bear the orphan status. Additionally, the market has had favorable regulatory environment, having witnessed a record year for FDA/EU/Japan orphan designations in 2014."
NPSP: 45.97 (+0.01)

Progenics Pharmaceuticals Announces the Appointment of Patrick Fabbio as Chief Financial Officer
GlobeNewswire - Mon Nov 16, 6:30AM CST
Progenics Pharmaceuticals, Inc. (Nasdaq GNX) today announced appointment of Patrick Fabbio as Chief Financial Officer. Mr. Fabbio, the former Vice President, Global Corporate Finance at NPS Pharmaceuticals, Inc., has over 20 years of financial experience in the healthcare sector at both publicly-traded and privately-held companies.
PGNX: 5.47 (+0.03), NPSP: 45.97 (+0.01)

Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025
PR Newswire Europe - Tue Nov 03, 11:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/hcv3cc/global [http://www.researchandmarkets.com/research/hcv3cc/global]) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" [http://www.researchandmarkets.com/research/hcv3cc/global] report to their offering.
BIIB: 252.77 (+1.47), UTHR: 111.16 (+1.58), CTIC: 0.35 (-0.01), CHRS: 17.70 (+0.48), JNJ: 122.95 (+0.10), NPSP: 45.97 (+0.01), IBIO: 0.68 (unch), EBS: 30.04 (+0.46), SLXP: 172.96 (+0.15), AMGN: 161.00 (-0.10), SPPI: 6.75 (-0.04), LLY: 79.65 (-0.01), GSK: 43.57 (+0.19), ANIK: 53.30 (+0.94), NVO: 54.99 (+0.43), BAX: 46.65 (+0.53), MRK: 59.59 (+0.24), NVS: 82.67 (+0.54)

Shire offers to buy Baxter drug spinoff for $30 billion
AP - Tue Aug 04, 3:29PM CDT
NEW YORK (AP) — The Irish drugmaker Shire is offering to buy Baxalta for about $30 billion in stock as it attempts to solidify its strengthening position in rare disease treatments.
BAX: 46.65 (+0.53), SHPG: 187.78 (-0.43), NPSP: 45.97 (+0.01), BXLT: 46.02 (-0.18)

Uptrend Call Working As NPS Pharmaceuticals Stock Rises 63.6% (NPSP)
Comtex SmarTrend(R) - Mon Apr 20, 11:12AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

63.6% Return Seen to Date on SmarTrend NPS Pharmaceuticals Call (NPSP)
Comtex SmarTrend(R) - Mon Apr 13, 10:06AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

NPS Pharmaceuticals Shares Up 63.6% Since SmarTrend's Buy Recommendation (NPSP)
Comtex SmarTrend(R) - Mon Apr 06, 9:18AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

Shares of NPSP Up 63.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 26, 4:47PM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 5 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

NPS Pharmaceuticals Has Returned 63.6% Since SmarTrend Recommendation (NPSP)
Comtex SmarTrend(R) - Thu Mar 19, 11:16AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 5 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

Cynapsus Therapeutics Appoints Tamar Howson to Board of Directors
BusinessWire - Thu Mar 12, 3:10PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced that Tamar Howson has been appointed to the Company's Board of Directors. With the addition of Ms. Howson to the Board of Directors, the Company now has eight directors, with seven directors classified as independent.
OXGN: 0.70 (-0.03), NPSP: 45.97 (+0.01), BMY: 76.20 (+0.92), CTH.TO: 21.24 (+0.24)

Will NPS Pharmaceuticals (NPSP) Miss on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 12:00PM CST
NPS Pharmaceuticals (NPSP), which is expected to report fourth-quarter 2014 results on Feb 17, had posted a negative earnings surprise of 300% in the last quarter.
ACT: 298.98 (-2.94), SHPG: 187.78 (-0.43), NPSP: 45.97 (+0.01), ARIA: 7.51 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 21

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 22

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 29

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 23

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 24

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 23

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 26

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 25

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 20

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 10

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading

Top 5 Most Recently Viewed Articles

Martech's Awakening: Queen One's Bold Move

Updated Category News Views 102

The SaaS Scene Just Got a Shake-Up Queen One's entrance into the CRM market isn't a gentle splash—it's a tidal wave. The founder, Maricor Resente, isn’t pulling any punches. With a claim to never pay full price and the launch of the Queen One CRM, they’re stirring the pot in the martech ecosystem, aiming to deliver world-scale tech that’s tough on the pocketbook...

Continue Reading
Kerry W. Kirby Advocates for Affordable Housing Solutions

Updated Category News Views 59

Tackling the Affordable Housing Crisis In an engaging webcast titled Creating Change: Tech Giant Amazon Ramps Up Investments in Affordable Housing, notable entrepreneur Kerry W. Kirby explores the urgent issue of affordable housing. Joined by industry experts like Ernest F. Oriente, the session sheds light on the challenges that communities are currently facing and...

Continue Reading
Exxon Mobil Partners with LG Chem for Lithium Supply Agreement

Updated Category News Views 65

Exxon Mobil's Strategic Partnership with LG Chem Exxon Mobil Corporation (NYSE: XOM) has recently entered into a non-binding memorandum of understanding (MOU) with LG Chem, a prominent chemical company. This significant agreement aims to supply up to 100,000 metric tons of lithium carbonate from Exxon Mobil's forthcoming domestic project to support LG Chem's expansive...

Continue Reading
Angelalign Technology's Global Growth and Innovation Drive Success

Updated Category News Views 369

Angelalign Technology Reports Significant Growth in 2024 Angelalign Technology Inc. (6699.HK) has demonstrated impressive financial performance for the fiscal year 2024, fueled by its expansive growth into international markets and innovative approaches in digital orthodontics. Despite challenging global market conditions, the Company has successfully navigated these...

Continue Reading
Best Crypto Exchanges Canada Elevates Investor Insights

Updated Category News Views 183

Best Crypto Exchanges Canada Elevates User Experience In a rapidly changing landscape like cryptocurrency, clarity and trusted information are key. Best Crypto Exchanges Canada has taken a significant step forward by launching its enhanced ranking filters. This initiative comes at a crucial time when investors are seeking reliable resources to make informed trading...

Continue Reading